Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer

被引：0
|
作者：
Maruyama, Kohei [1 ,2 ]
Suzuki, Mai [1 ,2 ]
Ohhara, Tomoko [1 ]
Nagayama, Satoshi [3 ]
Fujita, Naoya [4 ]
Katayama, Ryohei [1 ,2 ]
机构：
[1] JFCR, Div Exp Chemother, Canc Chemother Ctr, Tokyo, Japan
[2] Univ Tokyo, Dept CBMS, Grad Sch Front Sci, Tokyo, Japan
[3] JFCR, Canc Inst Hosp, Dept Surg Gastroenterol, Tokyo, Japan
[4] JFCR, Canc Chemother Ctr, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2032
引用
收藏
页码：783 / 783
页数：1
相关论文
共 50 条
  • [1] Intrinsic resistance mechanisms to mutant KRAS specific inhibitor in KRAS mutated colorectal cancer
    Maruyama, Kohei
    Suzuki, Mai
    Ohhara, Tomoko
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    CANCER SCIENCE, 2023, 114 : 1210 - 1210
  • [2] Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization
    Maruyama, Kohei
    Shimizu, Yuki
    Nomura, Yumi
    Oh-hara, Tomoko
    Takahashi, Yuki
    Nagayama, Satoshi
    Fujita, Naoya
    Katayama, Ryohei
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [3] Mechanisms of Resistance to MEK Inhibitor AZ6244 in KRAS Mutant Metastatic Colorectal Cancer
    Gambino, V.
    Sun, C.
    Prahallad, A.
    Tzani, A.
    Grernrum, W.
    Mittempergher, L.
    Bernards, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 174 - 174
  • [4] QUANTITATIVE MEASUREMENT OF KRAS MUTATED ALLELES IN PLASMA AS PROGNOSTIC MARKER IN METASTATIC KRAS MUTANT COLORECTAL CANCER
    Spindler, K.
    Pallisgaard, N.
    Andersen, R.
    Jakobsen, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 530 - 531
  • [5] Sotorasib in KRAS-Mutated Colorectal Cancer
    Fojo, Tito
    Fakih, Marwan G.
    Chao, Joseph
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02): : 186 - 187
  • [6] Mechanisms of KRAS Inhibitor Resistance Revealed
    Caruso, Catherine
    CANCER DISCOVERY, 2021, 11 (06) : 1311 - 1312
  • [7] Resistance mechanisms in KRAS-G12C-mutated cancer
    Gassa, Asmae
    Ozkan, Filiz
    Ast, David
    Wahlers, Thorsten
    Bruns, Christiane
    Alakus, Hakan
    ONKOLOGE, 2021, 27 (12): : 1243 - 1244
  • [8] Identification of intrinsic resistance mechanisms to KRAS-G12C inhibitor using patient derived colorectal cancer cells
    Maruyama, Kohei
    Shimizu, Yuki
    Suzuki, Mai
    Ohhara, Tomoko
    Fujita, Naoya
    Nagayama, Satoshi
    Katayama, Ryohei
    CANCER SCIENCE, 2022, 113
  • [9] A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS
    Duan, Xiaohua
    Zhang, Tuo
    Feng, Lingling
    de Silva, Neranjan
    Greenspun, Benjamin
    Wang, Xing
    Moyer, Jenna
    Martin, M. Laura
    Chandwani, Rohit
    Elemento, Olivier
    Leach, Steven D.
    Evans, Todd
    Chen, Shuibing
    Pan, Fong Cheng
    CELL STEM CELL, 2024, 31 (01) : 71 - 88.e8
  • [10] Radiosensitization with the c-MET inhibitor crizotinib in KRAS mutant colorectal cancer
    Cuneo, Kyle C.
    Kurapati, Himabindu
    Mehta, Ranjit
    Lawrence, Theodore S.
    Nyati, Mukesh K.
    CANCER RESEARCH, 2017, 77
12345